Table 6. The influence of longer operative time on EAD and EAD type B in the validation cohort.

Variables	High risk group (n=297)				Low risk group (n=204)
	Long operative time (>6 h, n=108)	Short operative time (≤6 h, n=189)	P		Long operative time (>6 h, n=95)	Short operative time (≤6 h, n=109)	P
EAD incidence			0.005				0.062
EAD	68 (62.96)	87 (46.03)			28 (29.47)	20 (18.35)
Non-EAD	40 (37.04)	102 (53.97)			67 (70.53)	89 (81.65)
EAD type B incidence			0.020				0.053
EAD type B	30 (27.78)	31 (16.40)			10 (10.53)	4 (3.67)
Non-EAD type B	78 (72.22)	158 (83.60)			85 (89.47)	105 (96.33)

EAD, early allograft dysfunction